Working towards the next breakthrough in diabetes

– Meet the people behind our treatment pipeline

Erica works in diabetes research at Novo Nordisk

In the film below, Scientific Director of Diabetes Biology, Erica Nishimura, shows us how she takes "little steps every day…" towards the next scientific breakthrough in diabetes care. For Erica, it is the brainstorming in multi-disciplinary teams and reaching out to external experts in the field that gives her the insight she needs to move her research closer to the goal of finding the ultimate therapeutic insulin that only lowers blood glucose when necessary.

Searching for the 'holy grail' in insulin treatment



Diabetes research at Novo Nordisk

Our science is driven by a determination to improve treatment options and advance the search for a cure for diabetes. 

Our comprehensive diabetes portfolio is a key differentiator because it demonstrates our commitment to deliver needs-based treatments that empower people with diabetes to live life on their own terms.



Other portraits in this series

 
Protein
discovery
 
Haemophilia research Inflammation research Device
innovation
 

 



 

  •  

Learn more about Novo Nordisk's commitment to people with diabetes:

DAWN2 Study (Diabetes, Attitudes, Wishes and Needs)

Changing Diabetes® 

Novo Nordisk World Diabetes Foundation

  •  
  •  

Type 1 diabetes centre opened in Seattle

The Novo Nordisk Type 1 Diabetes R&D Center opened 13 June, 2012 in Seattle, Washington. The centre, led by Matthias von Herrath, will work closely with academic and biotech partners, as well as conduct in-house research to develop potential new treamtent solutions for patients.

Learn more about the new centre 

  •